NO20062723L - Ikke-tabletterte, tyggbare, induviduelt doserte administrasjonsformer - Google Patents

Ikke-tabletterte, tyggbare, induviduelt doserte administrasjonsformer

Info

Publication number
NO20062723L
NO20062723L NO20062723A NO20062723A NO20062723L NO 20062723 L NO20062723 L NO 20062723L NO 20062723 A NO20062723 A NO 20062723A NO 20062723 A NO20062723 A NO 20062723A NO 20062723 L NO20062723 L NO 20062723L
Authority
NO
Norway
Prior art keywords
tableted
composition
water
stabilizing agent
individually dosed
Prior art date
Application number
NO20062723A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Luis Fabregas Vidal
Antoni Masso Carbonell
Nuria Garcia Gonzalez
Pere Guiro Coll
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34610359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062723(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of NO20062723L publication Critical patent/NO20062723L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20062723A 2003-11-10 2006-06-12 Ikke-tabletterte, tyggbare, induviduelt doserte administrasjonsformer NO20062723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200302612A ES2235626B1 (es) 2003-11-10 2003-11-10 Formas de administracion masticables, no comprimidas dosificadas individualmente.
PCT/EP2004/012658 WO2005048974A2 (en) 2003-11-10 2004-11-09 Non-tabletted, chewable, individually dosed administration forms

Publications (1)

Publication Number Publication Date
NO20062723L true NO20062723L (no) 2006-06-12

Family

ID=34610359

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062723A NO20062723L (no) 2003-11-10 2006-06-12 Ikke-tabletterte, tyggbare, induviduelt doserte administrasjonsformer

Country Status (25)

Country Link
US (1) US20070134318A1 (xx)
EP (1) EP1682097B1 (xx)
JP (1) JP4879021B2 (xx)
KR (1) KR20060116821A (xx)
CN (1) CN1878542A (xx)
AR (1) AR048050A1 (xx)
AT (1) ATE492270T1 (xx)
AU (1) AU2004290517B2 (xx)
BR (1) BRPI0416215A (xx)
CA (1) CA2548615A1 (xx)
CO (1) CO5690531A2 (xx)
DE (1) DE602004030706D1 (xx)
EC (1) ECSP066553A (xx)
ES (2) ES2235626B1 (xx)
IL (1) IL175285A (xx)
MY (1) MY143793A (xx)
NO (1) NO20062723L (xx)
NZ (1) NZ546375A (xx)
PE (1) PE20050488A1 (xx)
RU (1) RU2369379C2 (xx)
TW (1) TW200526266A (xx)
UA (1) UA90253C2 (xx)
UY (1) UY28586A1 (xx)
WO (2) WO2005048975A1 (xx)
ZA (1) ZA200602416B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
AU2007288253B2 (en) 2006-08-23 2013-05-02 Xenon Pharmaceuticals Inc. Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
KR20090083479A (ko) 2006-11-28 2009-08-03 밸리언트 파마슈티컬즈 인터내셔널 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
CN101686942B (zh) * 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
EP2238976B1 (en) * 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
JP5770173B2 (ja) 2009-06-25 2015-08-26 アルコブラ、リミテッドＡｌｃｏｂｒａ Ｌｔｄ． 認知疾患、障害または病態の治療、症状緩和、軽減、改善および予防方法
EA021368B1 (ru) * 2011-06-21 2015-06-30 Общество С Ограниченной Ответственностью "Консорциум-Пик" Препарат кардиопротекторного действия
CN105911057B (zh) * 2016-06-22 2018-10-19 扬州一洋制药有限公司 一种铝镁加混悬液的质量控制方法
CN113425694A (zh) * 2021-07-02 2021-09-24 杭州蚕宝生物技术有限公司 一种石斛生物碱口腔崩解片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645411A (en) * 1979-09-20 1981-04-25 Taiho Yakuhin Kogyo Kk Poultice
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JPH0912463A (ja) * 1995-06-23 1997-01-14 Fujisawa Pharmaceut Co Ltd 口中咀嚼用製剤
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6060078A (en) * 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6652880B1 (en) * 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
AU2002231970B2 (en) * 2001-02-14 2007-08-16 GW Research Limited Mucoadhesive pharmaceutical formulations
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration

Also Published As

Publication number Publication date
AU2004290517B2 (en) 2010-05-27
DE602004030706D1 (de) 2011-02-03
BRPI0416215A (pt) 2006-12-26
JP2007510690A (ja) 2007-04-26
ATE492270T1 (de) 2011-01-15
EP1682097B1 (en) 2010-12-22
EP1682097A2 (en) 2006-07-26
NZ546375A (en) 2009-11-27
ES2358332T3 (es) 2011-05-09
MY143793A (en) 2011-07-15
TW200526266A (en) 2005-08-16
WO2005048974A2 (en) 2005-06-02
US20070134318A1 (en) 2007-06-14
WO2005048975A1 (en) 2005-06-02
ECSP066553A (es) 2006-12-20
CN1878542A (zh) 2006-12-13
CA2548615A1 (en) 2005-06-02
AR048050A1 (es) 2006-03-29
UA90253C2 (ru) 2010-04-26
ES2235626A1 (es) 2005-07-01
CO5690531A2 (es) 2006-10-31
UY28586A1 (es) 2005-05-31
IL175285A (en) 2011-04-28
ES2235626B1 (es) 2006-11-01
KR20060116821A (ko) 2006-11-15
PE20050488A1 (es) 2005-08-24
RU2006120087A (ru) 2007-12-27
AU2004290517A1 (en) 2005-06-02
JP4879021B2 (ja) 2012-02-15
RU2369379C2 (ru) 2009-10-10
IL175285A0 (en) 2006-09-05
ZA200602416B (en) 2009-06-24
WO2005048974A3 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
NO20062723L (no) Ikke-tabletterte, tyggbare, induviduelt doserte administrasjonsformer
ES2575994T3 (es) Sistema y procedimiento para preparar, aplicar y retirar un revestimiento superior para gráficos despegables
BR0309004A (pt) Matriz para liberação gradual, invariante e independente dos compostos ativos
DE69901951T2 (de) Verwendung gelierbarer pharmazeutischer zusammensetzungen in der parodontologie
EA200101266A1 (ru) Новый препарат и форма для введения, включающие неустойчивое в кислой среде действующее вещество
TR200102504T2 (tr) Jelatinsiz hızlı dağılan dozaj formları.
ES459743A1 (es) Un metodo para preparar una composicion farmaceutica pulve- rizable para aplicacion topica a la piel danada de seres hu-manos y animales.
NZ305893A (en) Pharmaceutical composition comprising a polymeric release material, active ingredient, a transcutaneous absorption promotor and a non-aqueous solvent which forms a flexible film on contact with skin
ME00675B (me) Čvrste lipidne smeše
KR870003772A (ko) 2-(2-플루오로-4-비페닐릴)프로피온산을 함유하는 약제학적 조성물의 제조방법
CA1169770A (en) Antimycotic agent, in the form of sticks, with a high release of active compound
NZ598554A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
JP2007510690A5 (xx)
CO4560593A1 (es) Adhesivos para corrugado que emplean fibra de tapioca
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
FI935051A0 (fi) Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser
CN103396696A (zh) 可生物降解的环保型脱漆剂
NO20031225L (no) Fremgangsmåte for fremstilling av råstoffer for utvinning av konjugert linolsyre
JPS5712029A (en) Modification of cellulose ether film
JPS63280017A (ja) 軟カプセル用の皮膜組成物
Shehab et al. Studies on the in vitro release of ibuprofen from polyethylene glycol-polyvinyl acetate mixtures liquid filled into hard gelatin capsules
US5707651A (en) Soft capsules containing dinreburnamenine compounds
TH73462A (th) รูปยาสำหรับการให้ยาที่กำหนดขนาดยาไว้ในแต่ละหน่วยที่เคี้ยวได้และไม่ได้ทำให้เป็นยาเม็ด
CN107669633A (zh) 一种水包油型非班太尔纳米乳及其制备方法
SE8401748D0 (sv) Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application